<DOC>
	<DOCNO>NCT00691808</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , effectiveness 2 dose level LX6171 give 28 day patient Age Associated Memory Impairment ( AAMI ) .</brief_summary>
	<brief_title>Study LX6171 Elderly Volunteers With Age Associated Memory Impairment</brief_title>
	<detailed_description />
	<mesh_term>Memory Disorders</mesh_term>
	<criteria>Males female age 6080 year old . Complaints memory loss everyday life Nonsmokers light smoker ( 10 cigarettes/day ) Negative urine screen drug abuse Ability provide write informed consent History evidence disease , disorder injury could cause cognitive deterioration . Need medication hormone replacement therapy , daily vitamin , overthecounter pain killer Clinically significant abnormality electrocardiogram History alcoholism drug dependence Use dietary supplement contain Huperzine A , gingko biloba , phosphatidylserine , Docosahexaenoic acid ( DHA )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>